TherapeuticsMD Inc (TXMD): TXMD from NYSE to Nasdaq

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

TherapeuticsMD Inc (TXMD)

Reply Private New

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	260
Posts	18197
Boards Moderated	0
Alias Born	01/19/2006

Re: None

Monday, 10/09/2017 8:47:21 AM

Monday, October 09, 2017 8:47:21 AM

TXMD from NYSE to Nasdaq

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent TXMD News

Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2024 09:00:30 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/26/2024 09:40:29 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/23/2024 10:18:08 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/12/2024 09:16:27 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 08:10:09 PM
TherapeuticsMD Announces Second Quarter 2024 Financial Results • Business Wire • 08/12/2024 08:05:00 PM
Form AW - Amendment Withdrawal Request • Edgar (US Regulatory) • 06/14/2024 09:00:03 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 08:18:59 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/10/2024 08:15:43 PM
TherapeuticsMD Announces First Quarter 2024 Financial Results • Business Wire • 05/10/2024 08:05:00 PM
TherapeuticsMD Announces Full Year 2023 Financial Results • Business Wire • 03/29/2024 08:00:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/07/2023 09:51:56 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/06/2023 04:36:35 PM
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 11/17/2023 02:28:51 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/17/2023 02:27:23 PM
TherapeuticsMD Announces Third Quarter 2023 Financial Results • Business Wire • 11/14/2023 09:05:00 PM

More TXMD News

InvestorsHub NewsWire

FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM

FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM

Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM

VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM

Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM

HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow